Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02470585 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1140

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision not related to patient safety

Conditions

Ovarian Cancer
Ovarian Neoplasm

Interventions

DRUG: Veliparib
DRUG: Paclitaxel
DRUG: Carboplatin
OTHER: Placebo to Veliparib

Sponsor

AbbVie

Collaborators

[object Object]